In fact, TP53 alterations have been detected in 10%-35% of poorly differentiated thyroid tumors, and up to 80% in anaplastic thyroid carcinoma, while no TP53 mutations are usually detected in conventional DTC.26 This evidence concerns the gene TP53 and thyroid gland undifferentiated (anaplastic) carcinoma.